ConductScience.org, home

Paper29655835

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.

Kirchgesner J and 5 others. Gastroenterology, 2018. Cited by 485 papers, by iCite.

Cite this record

ConductScience Library. Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. Papers, record 29655835. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29655835

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
PubMed
Journal
Gastroenterology
PubMed
Year
2018
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
485
iCite
Relative citation ratio, by iCite
21.2
iCite
Revised in PubMed
2026-01-27
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kirchgesner JJulien
2Lemaitre MMagali
3Carrat FFabrice
4Zureik MMahmoud
5Carbonnel FFranck
6Dray-Spira RRosemary

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppressive AgentsMajor topic
Inflammatory Bowel DiseasesMajor topic
Opportunistic InfectionsMajor topic
Adult
Drug Therapy, Combination
Female
Follow-Up Studies
France
Humans
Male
Middle Aged
Proportional Hazards Models
Risk Assessment
Severity of Illness Index
Young Adult

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in29966613Illuminating the Black Box: The Real Risk of Serious Infection With Inflammatory Bowel Disease Therapies.https://conductscience.org/library/papers/29966613

Source PubMed

Download CSV of comments and corrections

Cited by282

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 485 citations.

PMIDTitleJournalYearIn PapersSource
42928005[KASID Guidelines for the Medical Treatment of Crohn's Disease: 2026].Korean J Gastroenterol2026https://conductscience.org/library/papers/42928005PubMed
42803770Cloud-Based and Locally Deployed Language Models in Nursing and Health Care: An AI Act-Aligned Framework.JMIR Med Inform2026https://conductscience.org/library/papers/42803770PubMed
42536534A systematic review and meta-analysis of acupuncture for intestinal protection and underlying mechanisms in animal models of ulcerative colitis.Medicine (Baltimore)2026https://conductscience.org/library/papers/42536534PubMed
42503158Successful transition to mirikizumab following hepatic abscess during adalimumab therapy in a patient with ulcerative colitis.Clin J Gastroenterol2026https://conductscience.org/library/papers/42503158PubMed
42465743Engineered Escherichia coli Nissle 1917 secreting anti-TNF-α nanobody as a single-strain live biotherapeutic for inflammatory bowel disease.Front Immunol2026https://conductscience.org/library/papers/42465743PubMed
42336275Protection or Vulnerability? The Context-Dependent Memory of Intestinal Inflammation.Cell Mol Gastroenterol Hepatol2026https://conductscience.org/library/papers/42336275PubMed
42334197Respiratory syncytial virus incidence and clinical outcomes in patients with inflammatory bowel disease: a National Veterans Affairs cohort study.Inflamm Bowel Dis2026https://conductscience.org/library/papers/42334197PubMed
42220316Beta-Glucan modulates monocyte plasticity and differentiation capacity to mitigate DSS-induced colitis.Elife2026https://conductscience.org/library/papers/42220316PubMed
42209193From preclinical phase of Crohn's disease to postoperative recurrence: shared mechanisms and potential interventions.Gut2026https://conductscience.org/library/papers/42209193PubMed
42195197Ear, Nose, and Throat Manifestations in Inflammatory Bowel Diseases: A Systematic Review of the Clinical Spectrum.Medicina (Kaunas)2026https://conductscience.org/library/papers/42195197PubMed
42059639Immunological mechanism behind reactivated cryptococcosis in persistently infected mice following FTY720 treatment.Infect Immun2026https://conductscience.org/library/papers/42059639PubMed
42045813Exploring alterations in the gut resistome in medically treated inflammatory bowel disease patients.BMC Microbiol2026https://conductscience.org/library/papers/42045813PubMed
42027412Influenza vaccine uptake among patients with inflammatory bowel disease: comparable outcomes between telemedicine and in-person care.Crohns Colitis 3602026https://conductscience.org/library/papers/42027412PubMed
42026959[Advanced Combination Therapy in Inflammatory Bowel Disease].Korean J Gastroenterol2026https://conductscience.org/library/papers/42026959PubMed
41976865Adverse Events in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Nationwide, Population-Based, Propensity-Matched Cohort Study.J Clin Med2026https://conductscience.org/library/papers/41976865PubMed
41949596Tofacitinib safety in inflammatory bowel disease: a disproportionality analysis of the FDA adverse event reporting system.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41949596PubMed
41930211Analysis of the use of monoclonal antibodies in the treatment of Crohn's disease.Antib Ther2026https://conductscience.org/library/papers/41930211PubMed
41869355Case report: Tumor-like mediastinal tuberculous lymphadenitis with paravertebral cold abscess under cumulative immunosuppression: a case highlighting altered host-pathogen interactions.Front Immunol2026https://conductscience.org/library/papers/41869355PubMed
41828431Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease.Int J Mol Sci2026https://conductscience.org/library/papers/41828431PubMed
41821816Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges.Front Gastroenterol (Lausanne)2023https://conductscience.org/library/papers/41821816PubMed

See all 282 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29655835

GET https://conductscience.org/api/papers/v1/29655835/cited_by?page=2